Kyra van der Pan,Sandra de Bruin-Versteeg,Daniela Damasceno,Alejandro Hernández-Delgado,Alita J. van der Sluijs-Gelling,Wouter B. L. van den Bossche,Inge F. de Laat,Paula Díez,Brigitta A. E. Naber,Annieck M. Diks,Magdalena A. Berkowska,Bas de Mooij,Rick J. Groenland,Fenna J. de Bie,Indu Khatri,Sara Kassem,Anniek L. de Jager,Alesha Louis,Julia Almeida,Jacqueline A. M. van Gaans-van den Brink,Alex-Mikael Barkoff,Qiushui He,Gerben Ferwerda,Pauline Versteegen,Guy A. M. Berbers,Alberto Orfao,Jacques J. M. van Dongen,Cristina Teodosio

Abstract:Innate myeloid cell (IMC) populations form an essential part of innate immunity. Flow cytometric (FCM) monitoring of IMCs in peripheral blood (PB) has great clinical potential for disease monitoring due to their role in maintenance of tissue homeostasis and ability to sense micro-environmental changes, such as inflammatory processes and tissue damage. However, the lack of standardized and validated approaches has hampered broad clinical implementation. For accurate identification and separation of IMC populations, 62 antibodies against 44 different proteins were evaluated. In multiple rounds of EuroFlow-based design-testing-evaluation-redesign, finally 16 antibodies were selected for their non-redundancy and separation power. Accordingly, two antibody combinations were designed for fast, sensitive, and reproducible FCM monitoring of IMC populations in PB in clinical settings (11-color; 13 antibodies) and translational research (14-color; 16 antibodies). Performance of pre-analytical and analytical variables among different instruments, together with optimized post-analytical data analysis and reference values were assessed. Overall, 265 blood samples were used for design and validation of the antibody combinations and in vitro functional assays, as well as for assessing the impact of sample preparation procedures and conditions. The two (11- and 14-color) antibody combinations allowed for robust and sensitive detection of 19 and 23 IMC populations, respectively. Highly reproducible identification and enumeration of IMC populations was achieved, independently of anticoagulant, type of FCM instrument and center, particularly when database/software-guided automated ( vs. manual “expert-based”) gating was used. Whereas no significant changes were observed in identification of IMC populations for up to 24h delayed sample processing, a significant impact was observed in their absolute counts after >12h delay. Therefore, accurate identification and quantitation of IMC populations requires sample processing on the same day. Significantly different counts were observed in PB for multiple IMC populations according to age and sex. Consequently, PB samples from 116 healthy donors (8-69 years) were used for collecting age and sex related reference values for all IMC populations. In summary, the two antibody combinations and FCM approach allow for rapid, standardized, automated and reproducible identification of 19 and 23 IMC populations in PB, suited for monitoring of innate immune responses in clinical and translational research settings.

OMIP‐090: A 20‐parameter flow cytometry panel for rapid analysis of cell diversity and homing capacity in human conventional and regulatory T cells

OMIP‐061: 20‐Color Flow Cytometry Panel for High‐Dimensional Characterization of Murine Antigen‐Presenting Cells

OMIP 071: A 31‐Parameter Flow Cytometry Panel for In‐Depth Immunophenotyping of Human T‐Cell Subsets Using Surface Markers

OMIP-94: Twenty-four-color (thirty-marker) panel for deep immunophenotyping of immune cells in human peripheral blood

OMIP‐099: 31‐color spectral flow cytometry panel to investigate the steady‐state phenotype of human T cells

OMIP‐109: 45‐color full spectrum flow cytometry panel for deep immunophenotyping of the major lineages present in human peripheral blood mononuclear cells with emphasis on the T cell memory compartment

OMIP‐101: 27‐color flow cytometry panel for immunophenotyping of major leukocyte populations in fixed whole blood

OMIP‐100: A flow cytometry panel to investigate human neutrophil subsets

OMIP‐102: 50‐color phenotyping of the human immune system with in‐depth assessment of T cells and dendritic cells

OMIP‐095: 40‐Color spectral flow cytometry delineates all major leukocyte populations in murine lymphoid tissues

Eight-color panel for immune phenotype monitoring by flow cytometry

T lymphocyte immunophenotyping: 13-color flow cytometry panel design using the NovoCyte flow cytometer

OMIP 082: A 25‐color phenotyping to define human innate lymphoid cells, natural killer cells, mucosal‐associated invariant T cells, and γδ T cells from freshly isolated human intestinal tissue

OMIP 077: Definition of all principal human leukocyte populations using a broadly applicable 14-color panel

45-Color Full Spectrum Flow Cytometry Panel for Deep Immunophenotyping of the Major Lineages Present in Human Peripheral Blood Mononuclear Cells with Emphasis on the T cell Memory Compartment

Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring

Abstract 1392: Development of a human T cell backbone flow cytometry panel enabling flexibility in reagent choice while minimizing panel design challenges

Development of a standardized and validated flow cytometry approach for monitoring of innate myeloid immune cells in human blood

OMIP-079: Cell cycle of CD4+ and CD8+ naïve/memory T cell subsets, and of Treg cells from mouse spleen

Clinical applications of monitoring immune status with 90 immune cell subsets in human whole blood by 10-color flow cytometry

Standardization of Workflow and Flow Cytometry Panels for Quantitative Expression Profiling of Surface Antigens on Blood Leukocyte Subsets: An HCDM CDMaps Initiative